A Race Against Blindness Grants $1 Million Supporting Axovia Therapeutics’ Planned Clinical Trial for Bardet-Biedl Syndrome (BBS)

A Race Against Blindness announced today that they have granted Axovia Therapeutics funding to support our planned clinical trial for our lead program for BBS1, AXV-101. We are immensely grateful to the BBS community who came together to support this mission. Read more here.